Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$578,459
+$150,481 QoQ
Shares Held
2,131
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#511
of 846 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cambria Investment Management, L.P. holds $5,671,279 across 8 Diagnostics & Research names. NTRA ranks #3 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,532 | $2,773,523 | |
| 2 | DHR |
Danaher Corp /De/
|
5,128 | $976,781 | |
| 3 | NTRA |
Natera, Inc.
This page
|
2,131 | $578,459 | |
| 4 | WAT |
Waters Corp /De/
|
927 | $347,662 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
1,477 | $285,385 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
1,131 | $256,499 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
450 | $236,898 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
408 | $216,072 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $578,459 | 2,131 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $427,978 | 2,140 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $557,375 | 2,433 | Shares | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||